UBS Upgrades DaVita to Buy, Raises Price Target to $117
UBS analyst Andrew Mok upgrades DaVita (NYSE:DVA) from Neutral to Buy and raises the price target from $106 to $117.
Benzinga·08/19/2022 10:36:29
UBS analyst Andrew Mok upgrades DaVita (NYSE:
DVA) from Neutral to Buy and raises the price target from $106 to $117.